Estimates Revisions Decoy Therapeutics Inc.
Stocks
DCOY
US79400X6022
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:01 30/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.970 USD | -7.51% |
|
-48.83% | -74.70% |
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- DCOY Stock
- Consensus Decoy Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
